Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Starr

Orthopaedic Trauma Dallas, TX Medical Doctor

NPI 1861454928 CMS profile 357232

5323 Harry Hines Blvd, Dallas, TX 75390

Open in the dashboard

General payments

$111,316

218 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adam Starr of Dallas, TX is reported in the CMS Open Payments database as having received $111,316 across 218 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 87th percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $17,293 32
2024 General $24,242 35
2023 General $27,333 34
2022 General $8,222 36
2021 General $11,513 20
2020 General $1,799 13
2019 General $20,914 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Starr
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Adam Starr were reported at $17,293. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Adam Starr Orthopaedic Trauma median Middle half National median
2019 $20,914 $1,475 $264–$6,401 $163
2020 $1,799 $596 $120–$4,020 $114
2021 $11,513 $919 $171–$4,697 $132
2022 $8,222 $1,547 $272–$7,240 $149
2023 $27,333 $1,330 $247–$5,875 $160
2024 $24,242 $1,288 $277–$6,797 $164
2025 $17,293 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $63,738 88 payments
  2. OsteoCentric Technologies, Inc. $22,520 38 payments
  3. Biocomposites Inc $9,107 5 payments
  4. Arthrex, Inc. $7,981 17 payments
  5. Pylant Medical $2,272 30 payments
  6. Globus Medical, Inc. $2,158 9 payments
  7. Stryker Corporation $1,101 15 payments
  8. Skeletal Dynamics Inc $1,074 2 payments
  9. Philips Electronics North America Corporation $600 1 payment
  10. PolyNovo North America LLC $154 4 payments
  11. Other $611 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $54,102 24 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $32,425 3 payments
  3. Travel and Lodging $12,780 40 payments
  4. Food and Beverage $7,643 138 payments
  5. Education $3,685 4 payments
  6. Royalty or License $681 9 payments
Products named General payments · program years 2019–2025
  1. EVOS Trauma Plates, Screws, and Nails $50,328 28 payments
  2. EVOS Trauma Plates, Screws, and Nails $28,165 20 payments
  3. EVOS MINI $28,070 16 payments
  4. TRIGEN INTERTAN $26,876 9 payments
  5. EVOS Trauma Plates, Screws, and Nails $13,678 8 payments
  6. TAYLOR SPATIAL FRAME $12,650 1 payment
  7. TRIGEN $12,650 1 payment
  8. Unifi Technology $11,312 10 payments
  9. Stimulan $9,107 5 payments
  10. Peri-Loc $7,887 6 payments
  11. Other $49,260 143 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$26,336

Medicare's payments for the services billed

Medicare patients

32

Average age 76

Services billed

73

18 women, 14 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Chronic kidney disease 50%
Depression 47%
Diabetes 44%
Ischemic heart disease 44%
Osteoporosis 38%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

218 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record